Published in Neurology on April 01, 1996
Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors. J Neurosci (1997) 2.51
Status epilepticus of inflammatory etiology: a cohort study. Neurology (2015) 2.02
Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy. Pharmacol Ther (2004) 1.94
Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis. Acad Emerg Med (2010) 1.82
Prospective study of new-onset seizures presenting as status epilepticus in childhood. Neurology (2010) 1.69
Time from convulsive status epilepticus onset to anticonvulsant administration in children. Neurology (2015) 1.58
Incidence and outcome of convulsive status epilepticus in Kenyan children: a cohort study. Lancet Neurol (2008) 1.55
Age-dependent sex difference of the incidence and mortality of status epilepticus: a twelve year nationwide population-based cohort study in Taiwan. PLoS One (2015) 1.39
Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry (2005) 1.36
Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr (2016) 1.31
Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy. J Neurol (2008) 1.31
Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol (2011) 1.31
Safety of long-term video-electroencephalographic monitoring for evaluation of epilepsy. Mayo Clin Proc (2009) 1.29
Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry (2006) 1.20
Status epilepticus: an evidence based guide. BMJ (2005) 1.18
Inappropriate emergency management of status epilepticus in children contributes to need for intensive care. J Neurol Neurosurg Psychiatry (2004) 1.13
Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy. Neuroscience (2007) 1.09
Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy. Neurosci Lett (2006) 1.03
Origins of temporal lobe epilepsy: febrile seizures and febrile status epilepticus. Neurotherapeutics (2014) 1.03
The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists. J Neurol Neurosurg Psychiatry (2003) 1.02
Emergency management of febrile status epilepticus: results of the FEBSTAT study. Epilepsia (2014) 1.02
Outcome predictors for status epilepticus--what really counts. Nat Rev Neurol (2013) 1.00
Intravenous levetiracetam as treatment for status epilepticus. J Neurol (2009) 1.00
Single Unprovoked Seizures. Curr Treat Options Neurol (2004) 0.98
Poststroke Seizures and Epilepsy: Clinical Studies and Animal Models. Epilepsy Curr (2002) 0.98
Development of the calcium plateau following status epilepticus: role of calcium in epileptogenesis. Expert Rev Neurother (2009) 0.97
Effect of age on kainate-induced seizure severity and cell death. Neuroscience (2008) 0.97
The established status epilepticus trial 2013. Epilepsia (2013) 0.97
Clinical impact of primary infection with roseoloviruses. Curr Opin Virol (2014) 0.95
Hypothermia for pediatric refractory status epilepticus. Epilepsia (2013) 0.94
Treatment deviating from guidelines does not influence status epilepticus prognosis. J Neurol (2012) 0.94
Clinical review: status epilepticus. Crit Care (2002) 0.92
Effective treatments of prolonged status epilepticus in developing rats. Epilepsy Behav (2008) 0.91
Vulnerability of postnatal hippocampal neurons to seizures varies regionally with their maturational stage. Neurobiol Dis (2009) 0.91
Nonconvulsive status epilepticus: a diagnostic and therapeutic challenge in the intensive care setting. Ther Adv Neurol Disord (2011) 0.88
A comparison of three NMDA receptor antagonists in the treatment of prolonged status epilepticus. Epilepsy Res (2004) 0.88
A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage. Epilepsia (2011) 0.88
Functional network changes in hippocampal CA1 after status epilepticus predict spatial memory deficits in rats. J Neurosci (2012) 0.87
Febrile seizures: four steps algorithmic clinical approach. Iran J Pediatr (2010) 0.86
Risk factors associated with death in in-hospital pediatric convulsive status epilepticus. PLoS One (2012) 0.86
Intravenous levetiracetam in the rat pilocarpine-induced status epilepticus model: behavioral, physiological and histological studies. Neuropharmacology (2009) 0.85
The role of levetiracetam in treatment of seizures in brain tumor patients. Front Neurol (2013) 0.85
Prehospital Treatment of Status Epilepticus with Benzodiazepines Is Effective and Safe. Epilepsy Curr (2002) 0.85
Pathophysiological considerations of seizures, epilepsy, and status epilepticus in the elderly. Aging Dis (2011) 0.85
Comparisons of the mortality and clinical presentations of status epilepticus in private practice community and university hospital settings in Richmond, Virginia. Seizure (2009) 0.84
Electrographic seizures after convulsive status epilepticus in children and young adults: a retrospective multicenter study. J Pediatr (2013) 0.84
Status Epilepticus: Epidemiology and Public Health Needs. J Clin Med (2016) 0.82
Generalised convulsive status epilepticus: an overview. Postgrad Med J (2006) 0.82
Outcome of convulsive status epilepticus: a review. Arch Dis Child (2007) 0.82
Convulsive Status Epilepticus. Curr Treat Options Neurol (1999) 0.82
Endotracheal Intubation in Patients Treated for Prehospital Status Epilepticus. Neurocrit Care (2015) 0.82
Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits. Epilepsia (2016) 0.82
Effects of JAK2-STAT3 signaling after cerebral insults. JAKSTAT (2014) 0.80
Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application. Expert Rev Neurother (2015) 0.80
Impact of treatment on the short-term prognosis of status epilepticus in two population-based cohorts. J Neurol (2008) 0.79
Mortality Associated with Status Epilepticus. Epilepsy Curr (2004) 0.79
Status epilepticus. Ann Indian Acad Neurol (2009) 0.79
Prognostic factors of status epilepticus in children. Yonsei Med J (2005) 0.79
Evaluation of a clinical tool for early etiology identification in status epilepticus. Epilepsia (2014) 0.79
Therapeutic hypothermia for refractory status epilepticus in a child with malignant migrating partial seizures of infancy and SCN1A mutation: a case report. Ther Hypothermia Temp Manag (2012) 0.78
What are the effects of prolonged seizures in the brain? Epileptic Disord (2014) 0.78
Diagnosis and Treatment of Nonconvulsive Status Epilepticus in an Intensive Care Unit Setting. Curr Treat Options Neurol (2003) 0.78
Lessons from the laboratory: the pathophysiology, and consequences of status epilepticus. Semin Pediatr Neurol (2010) 0.78
Risk factors for complications of drug-induced seizures. J Med Toxicol (2011) 0.78
Benzodiazepine-refractory status epilepticus: pathophysiology and principles of treatment. Ann N Y Acad Sci (2016) 0.78
Status epilepticus in the elderly: epidemiology, clinical aspects and treatment. Neurol Int (2012) 0.77
Clinical significance of treatment delay in status epilepticus. Int J Emerg Med (2013) 0.77
Intravenous anesthesia in treatment of nonconvulsive status epilepticus: Characteristics and outcomes. Epilepsy Res (2015) 0.77
Temporal lobe epilepsy in the elderly. Epilepsy Res Treat (2011) 0.76
Animal models for the development of new neuropharmacological therapeutics in the status epilepticus. Curr Neuropharmacol (2006) 0.76
Neuroprotective effects of deep hypothermia in refractory status epilepticus. Ann Clin Transl Neurol (2015) 0.76
Predictive value of the Status Epilepticus Severity Score (STESS) and its components for long-term survival. BMC Neurol (2016) 0.75
Grand Rounds: An Update on Convulsive Status Epilepticus. Ulster Med J (2015) 0.75
Clinical Profile of Status epilepticus (SE) in Children in a Tertiary Care Hospital in Bihar. J Clin Diagn Res (2014) 0.75
Predictive value of S100-B and copeptin for outcomes following seizure: the BISTRO International Cohort Study. PLoS One (2015) 0.75
Status epilepticus: Using antioxidant agents as alternative therapies. Exp Ther Med (2016) 0.75
Elevation of Cardiac Troponins in Prolonged Status Epilepticus: A Retrospective Chart Analysis. SOJ Neurol (2015) 0.75
Predictors of hospital and one-year mortality in intensive care patients with refractory status epilepticus: a population-based study. Crit Care (2017) 0.75
Status epilepticus in the elderly: differential diagnosis and treatment. Neuropsychiatr Dis Treat (2011) 0.75
Epilepsy in the elderly: Special considerations and challenges. Ann Indian Acad Neurol (2014) 0.75
Selective changes in hippocampal GABAA receptors during status epilepticus. Epilepsy Curr (2009) 0.75
Status epilepticus: current treatment strategies. Neurohospitalist (2011) 0.75
Enhanced AMPA receptor-mediated neurotransmission on CA1 pyramidal neurons during status epilepticus. Neurobiol Dis (2017) 0.75
Seizures - just the tip of the iceberg: Critical care management of super-refractory status epilepticus. Indian J Crit Care Med (2016) 0.75
Levetiracetam improves disinhibitory behavior in nonconvulsive status epilepticus. Ann Gen Psychiatry (2014) 0.75
Management of Status Epilepticus in Children. J Clin Med (2016) 0.75
Adult Status Epilepticus: A Review of the Prehospital and Emergency Department Management. J Clin Med (2016) 0.75
Pentylenetetrazole-induced seizures in developing rats prenatally exposed to valproic acid. PeerJ (2016) 0.75
Symptomatic Epilepsies due to Cerebrovascular Diseases. Mater Sociomed (2014) 0.75
Status Epilepticus. Curr Treat Options Neurol (2002) 0.75
Acute and long-term effects of brivaracetam and brivaracetam-diazepam combinations in an experimental model of status epilepticus. Epilepsia (2017) 0.75
Simultaneous triple therapy for the treatment of status epilepticus. Neurobiol Dis (2017) 0.75
Acute Ischemic Stroke in Nonconvulsive Status Epilepticus-Underestimated? Results from an Eight-Year Cohort Study. J Stroke (2017) 0.75
Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol (1998) 5.54
Remission of seizures and relapse in patients with epilepsy. Epilepsia (1979) 4.17
Race-ethnic disparities in the impact of stroke risk factors: the northern Manhattan stroke study. Stroke (2001) 4.07
Phenomenology of prolonged febrile seizures: results of the FEBSTAT study. Neurology (2008) 3.83
The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia (1975) 3.67
Comparative safety of antiepileptic drugs during pregnancy. Neurology (2012) 3.32
Factors prognostic of unprovoked seizures after febrile convulsions. N Engl J Med (1987) 3.21
A population-based study of seizures after traumatic brain injuries. N Engl J Med (1998) 3.12
Determinants of mortality in status epilepticus. Epilepsia (1994) 3.03
The Washington Heights-Inwood Genetic Study of Essential Tremor: methodologic issues in essential-tremor research. Neuroepidemiology (1997) 2.96
Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology (2000) 2.86
A comparison of rectal diazepam gel and placebo for acute repetitive seizures. N Engl J Med (1998) 2.82
Localization of a gene for partial epilepsy to chromosome 10q. Nat Genet (1995) 2.72
Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke (1998) 2.70
The protective effect of moderate alcohol consumption on ischemic stroke. JAMA (1999) 2.68
Long-term mortality after a first episode of status epilepticus. Neurology (2002) 2.60
Epidemiology of status epilepticus. J Clin Neurophysiol (1995) 2.48
Derivation and validation of a clinical diagnostic model for chlamydial cervical infection in university women. JAMA (1990) 2.37
Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Arch Intern Med (1995) 2.33
The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics. Neurology (2005) 2.32
Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia (1999) 2.29
Seizure recurrence after a first unprovoked seizure. N Engl J Med (1982) 2.23
Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry (2008) 2.22
Cysticercosis and epilepsy: a critical review. Epilepsia (1998) 2.21
Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology (2001) 2.19
Hypertension and the risk of new-onset unprovoked seizures. Neurology (1993) 2.19
Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology (2004) 2.19
Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia (1998) 2.18
Estimating risk for developing epilepsy: a population-based study in Rochester, Minnesota. Neurology (2011) 2.06
Major depression is a risk factor for seizures in older adults. Ann Neurol (2000) 2.05
How common is the most common adult movement disorder? estimates of the prevalence of essential tremor throughout the world. Mov Disord (1998) 2.03
Race-ethnicity and determinants of carotid atherosclerosis in a multiethnic population. The Northern Manhattan Stroke Study. Stroke (1997) 2.00
A prospective study of recurrent febrile seizures. N Engl J Med (1992) 1.99
Differences in initial treatment patterns and outcomes of lung cancer in the elderly. Lung Cancer (1995) 1.95
Semistructured interview for seizure classification: agreement with physicians' diagnoses. Epilepsia (1990) 1.93
Lumping or splitting? "Ophthalmoplegia-plus" or Kearns-Sayre syndrome? Ann Neurol (1977) 1.90
Higher risk of seizures in offspring of mothers than of fathers with epilepsy. Am J Hum Genet (1988) 1.84
Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology (1998) 1.72
Reliability of seizure classification using a semistructured interview. Neurology (1993) 1.71
Verification of the fetal valproate syndrome phenotype. Am J Med Genet (1988) 1.71
Measuring standards of care for early breast cancer in an insured population. J Clin Oncol (1997) 1.71
Driving and epilepsy. A review and reappraisal. JAMA (1991) 1.69
LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology (2004) 1.67
Predictors of disease course in patients with probable Alzheimer's disease. Neurology (1987) 1.66
The risk of seizure recurrence after a first unprovoked afebrile seizure in childhood: an extended follow-up. Pediatrics (1996) 1.65
Discontinuing antiepileptic drugs in children with epilepsy: a prospective study. Ann Neurol (1994) 1.63
The risk of epilepsy following febrile convulsions. Neurology (1979) 1.61
Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology (1992) 1.61
Classification of partial seizure symptoms in genetic studies of the epilepsies. Neurology (2006) 1.59
Ability of Medicare claims data and cancer registries to identify cancer cases and treatment. Am J Epidemiol (1997) 1.58
Mortality in patients with epilepsy. Epilepsia (1980) 1.56
Predictors of multiple seizures in a cohort of children prospectively followed from the time of their first unprovoked seizure. Ann Neurol (2000) 1.56
Epidemiology of epilepsy. Adv Neurol (1978) 1.54
Seizures and myoclonus in patients with Alzheimer's disease. Neurology (1986) 1.53
Population-based study of seizure disorders after cerebral infarction. Neurology (1996) 1.52
Short-term mortality after a first episode of status epilepticus. Epilepsia (1997) 1.49
Relations of genetic and environmental factors in the etiology of epilepsy. Ann Neurol (1996) 1.47
Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus. Ann Neurol (1998) 1.46
Utility of electroencephalography in the pediatric emergency department. J Child Neurol (2001) 1.44
Autosomal dominant partial epilepsy with auditory features: defining the phenotype. Neurology (2000) 1.44
Incidence and prognosis of Bell's palsy in the population of Rochester, Minnesota. Mayo Clin Proc (1971) 1.42
Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes. Epilepsia (1999) 1.41
Risk factors for a first febrile seizure: a matched case-control study. Epilepsia (1995) 1.40
Dementia and adult-onset unprovoked seizures. Neurology (1996) 1.37
Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984. Epilepsia (1995) 1.37
The effect of age and comorbidity in the treatment of elderly women with nonmetastatic breast cancer. Arch Intern Med (1996) 1.35
Conversion of oxacillin-resistant staphylococci from heterotypic to homotypic resistance expression. Antimicrob Agents Chemother (2002) 1.32
Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology (2001) 1.31
Risk of recurrence after an initial unprovoked seizure. Epilepsia (1986) 1.31
Validity of telephone interview data for vascular disease risk factors in a racially mixed urban community: the Northern Manhattan Stroke Study. Neuroepidemiology (1999) 1.29
Causes of epilepsy: contributions of the Rochester epidemiology project. Mayo Clin Proc (1996) 1.28
Pregnancies of women with epilepsy: a population-based study in Iceland. Epilepsia (1998) 1.28
Variation in staging and treatment of local and regional breast cancer in the elderly. Breast Cancer Res Treat (1996) 1.27
Factors that determine the treatment for local and regional prostate cancer. Med Care (1996) 1.27
In whom does status epilepticus occur: age-related differences in children. Epilepsia (1997) 1.26
Clinical indicators of genetic susceptibility to epilepsy. Epilepsia (1996) 1.23
Predictors of recurrent febrile seizures: a metaanalytic review. J Pediatr (1990) 1.21
Psychologic and social adjustment to epilepsy in Rochester, Minnesota. Neurology (1989) 1.20
Severe, uncontrolled hypertension and adult-onset seizures: a case-control study in Rochester, Minnesota. Epilepsia (1996) 1.20
Are generalized and localization-related epilepsies genetically distinct? Arch Neurol (1998) 1.20
Occurrence of seizure clusters and status epilepticus during inpatient video-EEG monitoring. Neurology (2003) 1.19
Epidemiology and the genetics of epilepsy. Res Publ Assoc Res Nerv Ment Dis (1983) 1.19
Frequency and clinical determinants of dementia after ischemic stroke. Neurology (2000) 1.19
Alcohol consumption and withdrawal in new-onset seizures. N Engl J Med (1988) 1.19
Validity of family history data on seizure disorders. Epilepsia (1993) 1.18
Risk of seizure recurrence following a first unprovoked seizure in childhood: a prospective study. Pediatrics (1990) 1.17
Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial. Epilepsia (1994) 1.16
Nontraumatic coma. Glasgow coma score and coma etiology as predictors of 2-week outcome. Arch Neurol (1990) 1.16